Microbubbles and Ultrasound in Stroke Trial: MUST Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine whether transcranial 2-MHz ultrasound combined with intravenous administration of microbubbles improves early recanalization in patients with acute ischemic stroke caused by middle cerebral artery (MCA) proximal occlusion treated with intravenous alteplase within 3 hours of symptom onset.
| Condition | Intervention | Phase |
|---|---|---|
|
Acute Ischemic Stroke |
Radiation: Ultrasound Drug: Levovist |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
- Rate of early recanalization on post-treatment MR or CT angiography. Recanalization is described using the tIMI classification. [ Designated as safety issue: Yes ]
- Rate of symptomatic intracerebral hemorrhage, mortality, Score on the modified Rankin scale [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
| Enrollment: | 20 |
| Study Start Date: | June 2004 |
| Study Completion Date: | June 2004 |
| Primary Completion Date: | June 2004 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Levovist
|
Radiation: Ultrasound
2-MHz, low intensity transcranial ultrasound
Drug: Levovist
D-Galactose and palmitic palmitique intravenous 4 g
Other Name: Levovist
|
|
No Intervention: 2
No specific intervention
|
Detailed Description:
Proximal MCA occlusion is recognized using MR or CT angiography performed before inclusion. All patients are treated with alteplase according to current guidelines. In addition, patients randomized in the active group are continuously exposed to transcranial 2-MHz ultrasound for 1 hour combined with intravenous administration of microbubbles. Controls are only treated with alteplase. The ultrasound beam is positioned at the thrombus/blood flow interface using color-coded sonography. Galactose-based microbubbles are administered via continuous intravenous infusion over 40 min.
Early recanalization is assessed using MR or CT angiography 4 to 8 hours after symptom onset. The evaluation of angiograms is performed by 2 neuroradiologists blinded to group of randomization and clinical details. The primary outcome measure is the rate of early recanalization. Recanalization is assessed using the TIMI classification. Secondary endpoints include the rate of symptomatic intracerebral hemorrhage, mortality, and functional outcome on the modified Rankin scale at 3 months.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Acute ischemic stroke
- MCA proximal occlusion on CT or MR angiography
- Thrombolysis with intravenous alteplase initiated within 3 hours of stroke onset
Contacts and Locations| France | |
| Service de Neurologie | |
| Besancon, France, 25030 | |
| Service de Neurologie, Hôpital Gui de Chauliac | |
| Montpellier, France, 34295 | |
| Service de Neurologie, Hôpital Sainte Anne | |
| Paris, France, 75674 | |
| Service de Neurologie Vasculaire, University Hospital | |
| Toulouse, France, 31059 | |
| Service de Neurologie, University Hospital | |
| Tours, France, 37044 | |
| Principal Investigator: | LARRUE Vincent, MD | University Hospital Toulouse, FRANCE |
More Information
Additional Information:
Publications:
| Responsible Party: | LLAU Marie-Elise, University Hospital Toulouse |
| ClinicalTrials.gov Identifier: | NCT00222040 History of Changes |
| Other Study ID Numbers: | 0302208 |
| Study First Received: | September 15, 2005 |
| Last Updated: | April 29, 2010 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by University Hospital, Toulouse:
|
Stroke thrombolysis ultrasound microbubbles alteplase |
Additional relevant MeSH terms:
|
Stroke Cerebral Infarction Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Brain Ischemia |
ClinicalTrials.gov processed this record on May 19, 2013